Showing results (271-280 of 290) with videos related to
Sort By:
Pageof 29
Bioorganic & Medicinal Chemistry|January 22, 2019
Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitorsSebastian H Grimm, Berend Gagestein, Jordi F Keijzer, et al.The EMBO Journal|July 31, 2023
RNF26 binds perinuclear vimentin filaments to integrate ER and endolysosomal responses to proteotoxic stressTom Cremer, Lenard M Voortman, Erik Bos, et al.Nature|November 30, 2007
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1Coenraad Kuijl, Nigel D L Savage, Marije Marsman, et al.Cell|November 27, 2012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingSidong Huang, Michael Hölzel, Theo Knijnenburg, et al.ACS Chemical Biology|August 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, et al.Nature|April 30, 2010
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsPeter Duewell, Hajime Kono, Katey J Rayner, et al.Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.Cell Reports|December 4, 2023
The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferentJim Middelburg, Soroush Ghaffari, Tom A W Schoufour, et al.Nature Communications|February 4, 2026
Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxAArina Koroleva, Erika Artukka, Keith Yamada, et al.Journal for Immunotherapy of Cancer|March 10, 2022
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin STom J Harryvan, Marten Visser, Linda de Bruin, et al.Pageof 29